Key words: hyperparathyroidism; primary; secondary; chronic renal failure; haemodialysis; PRAD1; Ha-ras; Background. The genetic molecular anomalies in patients with primary (I°) and secondary ( II°) hyper-WT1; RET; allelic loss; rearrangement; Southern blot; fluorescence in situ hybridization (FISH ) parathyroidism (HPTH ) are still largely unknown. In particular, the changes underlying monoclonal growth in the parathyroids of patients with II°HPTH are not well understood.
Introduction
Methods. We screened genomic DNA from a total of 30 patients with I°HPTH and 29 patients with II°P rimary (I°) parathyroid adenomas are benign monouraemic HPTH for possible rearrangements or allelic clonal tumours, as demonstrated by Arnold et al. based losses of several gene markers located on chromosome on X-chromosome-inactivation analysis [1] . Recently 11p near the PTH gene, namely Ha-ras, IGF-2, WT1, it has been shown that secondary (II°) parathyroid and the PTH gene itself. In addition, two other gene hyperplasia due to chronic renal failure can lead to markers, PRAD1 ( localized on 11q13) and RET ( localmonoclonal, benign tumoural growth as well, at least ized on 10q11) were examined for possible structural in case of severe II°hyperparathyroidism (HPTH ) [2] . alterations. Moreover, we used fluorescence in situ Parathyroid tumorigenesis is still incompletely charachybridization ( FISH ) which is another technique to terized and understood. A variety of different molecudetect numerical alterations of chromosome 11. lar genetic abnormalities have been implicated in the Results. The results show that one of 13 patients with pathogenesis of parathyroid adenomas, including I°HPTH (8%) exhibited a rearrangement for the clonal rearrangement and overexpression of the cyclin PRAD-1 gene. Loss of heterozygosity of Ha-ras locus D1/PRAD1 oncogene, allelic losses on chromosome was observed in one of 11 uraemic patients with II°a rms 1p [3] and 11q [4] , and several recently discovered HPTH (9%). Three of 10 patients with I°HPTH (30%) deletions in chromosome regions 6q and 15q [5] . Loss and one of 7 patients with II°HPTH (14%) showed of heterozygosity of the 11q13 region is characteristic an allelic loss of the WT1 gene. No evidence of for patients with the multiple endocrine neoplasia type rearrangement or allelic loss was detected for the IGF-I (MEN-I ) syndrome [6, 7] , and germline point muta-2, PTH or RET genes respectively. Using FISH tions of the RET proto-oncogene are involved in the method, three normal parathyroid glands, six I°HPTH tumourigenesis of MEN-2A [8, 9] . Finally, an inactivaadenomas and eight II°HPTH hyperplastic glands tion of the RB tumour suppressor gene on 13q14 is from uraemic patients were studied with centromeric common in parathyroid carcinoma, but not in I°p robe for chromosome 11. Monosomy 11 was observed adenoma [10] . The molecular genetic anomalies in one case of I°HPTH and in one other case of involved in the pathogenesis of benign monoclonal II°HPTH.
tumours in uraemic patients with severe II°hyperpara-Conclusion. Evidence of loss of heterozygosity for sevthyroidism (HPTH ) are still unknown. eral genes located on human chromosome 11p has
The purpose of the present study was to examine been found in a series of parathyroid glands from possible rearrangements or allelic losses of genes locseveral patients with I°and II°uraemic HPTH, corresated on the short arm of chromosome 11 that are near ponding to monosomy of chromosome 11 in some the PTH gene, including the PTH gene itself, and the cases.
PRAD1 and RET genes located on 11q13 and 10q11 respectively in parathyroid gland tissues from patients several genes and gene markers possibly reflecting Southern blots analysis tumour suppressor genes in these chromosome regions.
Southern blot analysis was performed using 20 mg of para- 
Patients and tumour samples
formed at 42°C for 16 h in 6×SSC, 0.5% SDS (sodium dodecyl sulphate), 0.1% Denhardt's reagent, 5% dextran Parathyroid tissues and venous blood samples were obtained sulphate, salmon sperm DNA, and 50% formamide. After from 30 patients with I°HPTH and 29 patients with uraemic hybridization the filters were washed for 15 min in 2×SSC II°HPTH, all of whom had surgery at Saint Louis hospital, and 0.5% SDS at room temperature, and 15 min in 0.1×SSC Paris from December 1994 to January 1996. Patients with I°a nd 0.5% SDS at same temperature. The blots were auto-HPTH were aged 34-81 years (mean±SD, 58±14.0 years), radiographed for 4-7 days at −80°C. and uraemic patients on intermittent haemodialysis treatment Possible rearrangements or allelic losses of the marker with II°HPTH were aged 22-80 years (mean 48±14.8 (SD) genes studied could not be analysed in all 59 cases, either years). All patients had elevated serum intact parathyroid because the amount of DNA available was too limited or hormone (PTH 1-84 ) levels:182±178 pg/ml (mean±SD) in because the analysed loci were uninformative. patients with I°HPTH, and 963±569 pg/ml in patients with II°HPTH (normal range, 10-65 pg/ml ).
After surgical removal, tumour tissues were dissected and Fluorescence in situ hybridization (FISH) stored at −80°C until the extraction of DNA. All parathyroid tumours from patients with I°HPTH were classified The FISH method used was based on that described by as adenoma by pathological criteria; none had a feature Hopman et al. [19] . Briefly, frozen sections of normal and suggestive of malignancy. Hyperplastic parathyroid glands altered parathyroid glands were cut at thickness of 4-5 mm, removed from uraemic patients with II°HPTH were categor-fixed in a solution of 4% paraformaldehyde (30 min), rinsed ized either as diffuse hyperplasia or as nodular hyperplasia. in PBS and dehydrated in series of graded ethanol for 2 min. High-molecular-weight genomic DNA was extracted from Biotin-labelled, a-satellite DNA probe for chromosome 11 all parathyroid glands and peripheral venous blood samples and appropriate hybridization solutions were provided by by phenol-chloroform method.
Appligène Oncor (Illkirch, France). The slides were subsequently incubated in protein-digesting solution, rinsed in 2×SSC, and dehydrated in the series of graded ethanol. The specific probe in a hybridization mixture was added to each
DNA probes
tissue section, covered with plastic coverslip and incubated at 37°C for 2 h in a prewarmed humidified chamber. PostWe used five probes that have been mapped to chromosome hybridization washings were carried out at 72°C in 1×SSC 11, namely the PRAD1, Ha-ras, IGF-2, PTH, WT1 genes for 5 min. Detection of biotinylated DNA probe that hybridand one probe that has been mapped to chromosome 10, ized to the tissue section was visualized by indirect immunonamely the RET gene [11] . The following cDNA fragments fluorescence reaction using fluorescein-labelled avidin, by were used: the 1.4-kilobases (kb) EcoRI fragment of pGEM incubating the slides for 30 min at 37°C. The slides were 7Z f(+) plasmid containing human PRAD1 cDNA [12], the then washed three times for 2 min each in 40 ml of phosphate-3.0-kb Ha-ras insert obtained by SacI digestion of pBR322 buffered detergent solution (Oncor) at room temperature, [13], the 1.0-kb IGF-2 fragment from EcoRI digested pUC12 counterstained in a solution containing 10 mg/propidium [14], the 3.7-kb PTH cDNA obtained by EcoRI digestion iodide, and mounted in antifade solution. Sections were of pBR322 vector [15], the 1.0-kb WT1 insert from EcoRI examined with an epifluorescence microscope (Leica DMRB, digested WT33 plasmid [16 ] , and the RET specific cDNA Germany), equipped with the appropriate filters. Two hun-(clone pBSA3 obtained by Kpn-SacI digestion of pBSA3 dred to 1500 interphase nuclei were counted for each slide, vector) which has been kindly provided by Dr B. Ponder, except for normal tissue in which approximately 100 nuclei CRC Human Cancer Genetics Research group, Cambridge, were counted. The criteria applied to define the number of UK [17] . The locus name, the DNA probe, and genomic signals specific for chromosome 11 in our panel of tissues location were respectively: Ha-Ras (pEJ ras), chromosome were described by Brown et al. [20] . Only interphase cell 11p15; IGF-2 (pIGF2/8-1), 11p15; WT-1 ( WT33), 11p15; nuclei with intact morphology to which hybridization signals PRAD1 (pPL-8), 11q 13; PTH (p20.36, ATCC ), 11p15; and could be unambigously assigned were scored. At least 250 RET (pBSA3), 10q11. For chromosome 11p, altered para-nuclei were examined from different areas of a particular thyroids were classified as having loss of heterozygosity if tissue section by two different observers. To provide an loss was seen at any informative locus, and as non-unbiased analysis, centromere copy numbers in normal parainformative only if the patient was constitutionally homozy-thyroid gland samples were compared with those of pathologous for all the loci examined.
gical gland samples, establishing the cut-off values of the The probes were labelled with 32P by the random priming percentage of nuclei with 1 signal (monosomy) Á12%, and method [18] . The specific activity of the labelled probes was of the percentage of nuclei with 3 signals (trisomy) Á7%.
FISH analysis could not be performed in the majority of 8×108 c.p.m./mg DNA. cases screened for rearrangements or allelic losses due to PvuII restriction enzyme and hybridized with Ha-ras lack of tissue material. gene cDNA, no structural abnormality was detectable in any of the samples studied.
The findings of Southern blot analysis using WT1 Statistical analysis for FISH genomic probe are shown in Table 1 and Figure 1C . When the blots were hybridized with a WT1-specific Mean values±SE were compared by means of x2 analysis, with P<0.05 being regarded as statistically significant. We probe, a loss of the 5.0 kb WT1 band was detected in considered a true monosomy to be present when the percent-DNA restricted with the EcoRI enzyme in three of 10 age of nuclei with 1 signal in the normal parathyroid glands patients with I°HPTH (30%) and in one of seven exceeded the mean±4 SD (21). Accordingly, a monosomy patients with II°HPTH (14%) ( Figure 1C ). For comwas diagnosed when more than 50% of the nuclei counted parison, autologous peripheral blood DNA digested showed only 1 or no signal for chromosome 11.
with the EcoRI enzyme generated a hybridization pattern containing 14.3-kb, 5.5-kb, 5.0-kb, 3.6-kb, 3.3-kb, and 1.8-kb bands. A representative pattern of
Results
hybridization with loss of the 5.0-kb band in three patients with I°HPTH is shown in Figure 1C . Loss of Southern blot hybridization heterozygosity of the WT1 gene was also detected in the DNA of one hyperplastic gland from a patient The findings of gene rearrangements and deletions with II°HPTH, compared with control PBL DNA made with Southern blot analysis of our series of (not shown). Moreover, the intensity of hybridizing samples from patients with I°and II°HPTH are bands in DNA from adenomatous and hyperplastic summarized in Table 1 . After EcoRI digestion of autoltissues was half that in control DNA, also suggesting ogous control peripheral blood leukocyte DNA (PBL), a single gene copy. the PRAD-1 probe hybridized to 4.7-kb, 2.8-kb, and
Finally, Southern blot analysis of the same panel of 2.4-kb bands. In comparison, the hybridization pattern DNA samples, i.e. stemming from the parathyroid of DNA from the adenomatous tissue showed the tissues of patients with I°and II°HPTH, did not allow presence of a supplementary band of 3.3 kb to detect any rearrangement or allelic loss of the IGF-( Figure 1A ). Thus one of 13 patients with I°HPTH 2, PTH or RET genes respectively. (8%) showed a structural aberration compatible with a rearrangement of the PRAD-1 gene. In contrast, no such abnormality was detectable in DNAs extracted FISH analysis from the uraemic parathyroid tissues from patients with II°HPTH ( Table 1) .
Fluorescence in situ hybridization ( FISH ) with centromere-specific probe for chromosome 11 was performed Comparatively, Southern blot analysis of Ha-ras gene on DNA extracted from tissues of uraemic on specimens randomly selected from one normal parathyroid gland and from both I°and uraemic II°patients with II°HPTH showed loss of heterozygosity of this gene in one of 11 samples (9%). As shown in HPTH tissues. Table 2 shows the distribution of FISH findings in these tissues. Figure 1B , after the digestion of DNA of this hyperplastic tissue with PvuII restriction enzyme, a loss of Using the above-defined criteria, in normal parathyroid gland tissue, 51.9±2.8% of nuclei contained the 3.4 kb band was observed, compared with the restriction pattern of DNA from the peripheral blood. two hybridization signals, 37.8±1.0% one signal, and 10.3±2.1% no signal. None contained three signals In addition, the Ha-ras specific genomic probe revealed a decreased band intensity in tumour DNA, compared ( Table 2) .
For nuclei containing two signals, the distribution to the peripheral blood leukocytes DNA, which is consistent with the presence of a single gene copy. of hybridization signals was between 15.6 and 60.1% in parathyroid tissues from the six patients with I°Conversely, when control DNA and DNA from patients with adenomatous I°HPTH was digested with HPTH, and between 8.6 and 68.6% in tissues from the ( Table 2 ). In one case tissue from patient 3 with II°HPTH ( Figure 2B ) exhibiting only one hybridization signal per nucleus. of adenomatous I°HPTH tissue, parathyroid cells within the section exhibited a signal distribution of as This pattern indicates the presence of chromosome 11 monosomy in patient 3. The same monosomy pattern much as 64.8±3.0% to nuclei containing only one signal. Similarly, in one case of II°HPTH, there was was observed in patient 2 having I°HPTH. an elevated signal distribution of 58.5±2.5% in nuclei containing only one signal, revealing a monosomy of Discussion chromosome 11 in this pathological parathyroid gland sample. Figure 2 shows parathyroid cell nuclei in normal In the present study, four of the 27 parathyroid tissues sampled from patients with I°HPTH (11%), and two tissue (Figure 2A) exhibiting two hybridization signals per nucleus using FISH technique, and in hyperplastic of the parathyroid tissues obtained from patients with II°HPTH had evidence of various allelic losses on on chromosome 11p, near the PTH gene, and only one marker of the chromosome 11q region, namely chromosome 11, as detected by Southern blot analysis. These results are in agreement with previous observa-PRAD1. The findings from the Southern blot analysis were further confirmed using FISH with tions demonstrating partial deletions on chromosome 11q or entire allelic loss of this chromosome in chromosome 11-specific centromeric probe. According to our criteria for the classification of numerical aberra-25-29% of sporadic parathyroid adenomas [22] [23] [24] . The finding of allelic losses in our samples with a tions, we considered monosomy 11 to be the correct cytogenetic diagnosis in the parathyroid tissue sections slightly lower frequency than in previous studies may be due to the fact that we examined mainly markers of one patient with I°HPTH and of one other patient with II°HPTH in our series. The FISH results are in for allelic loss on 11q13, in accord with our previous report [2] . accordance with a recent report by Tahara et al. [5] , who detected allelic loss of chromosome 11 in 32% of In I°parathyroid adenoma, allelic losses have been detected in loci other than those located on chromoI°parathyroid adenomas using a panel of 10 polymorphic markers distributed along chromosome 11. some 11. For example, one or more allelic losses of informative loci on chromosome 1 have been observed These observations are also in line with findings made in parathyroid tumours of patients with the in 10 of 25 adenomas (40%) by Cryns et al. [3] . This is the most common molecular genetic abnormality MEN-1 syndrome in which a deletion of the putative MEN-1 tumour suppressor gene on chromosome 11q13 reported to date in such tumours, strongly implicating a presumable tumour suppressor gene on distal 1p was described [22] . Another study reported loss of heterozygosity of HaRas and Apo-A1 genes in two (1p32-pter) in parathyroid tumorigenesis. The same group of authors recently reported evidence of the insulinomas removed from patients with the MEN-1 syndrome [6 ], similar to those present in parathyroid frequent occurrence of loss of heterozygosity in I°p arathyroid adenomas on chromosome arms 6q and lesions [6, 23] . Therefore it had been hypothesized initially that identical allelic deletions on chromo-15q [5] and on chromosome arm 9p [32] .
Since sporadic mutations in the p53 tumour supsome 11 are involved in the development of monoclonal tumours in various endocrine tissues of a given MEN-1 pressor gene, located on 17p13, represent the single most common genetic alteration in various forms of patient [25] whereas among different MEN-1 families the chromosomal regions of allelic loss could be differ-human cancer [33] such mutations have also been looked for in parathyroid tumours. No p53 point ent. However, recent studies have shown that even in a given MEN-1 patient, variable regions of chromo-mutations were found in parathyroid adenoma or carcinoma, except in one of nine parathyroid carcinsome 11 loss may occur in different pathological tissues [26 ] , and parathyroid neoplasms can consist of more omas with both p53 allelic loss and abnormal nuclear p53 protein staining [34, 35] . These findings could than one clone [27] .
In sporadic parathyroid tumours and hyperplasia, implicate the p53 gene in the pathogenesis of a subset of parathyroid carcinomas. However, the major genetic allelic loss at 11q13 is a less frequent finding than in those from MEN-1 patients [22], reflecting on one side molecular anomaly in the latter clearly is the recently reported loss of the RB gene [10] . the heterogeneity within sporadic tumours and on the other the role that inactivation of a tumour suppressor
Other potentially involved mutations in parathyroid tumours theoretically could implicate somatic genes gene in this chromosomal region has in parathyroid tumorigenesis [28] .
involved in the regulation of PTH synthesis and secretion. One possible candidate was the recently cloned In uraemic patients with severe II°HPTH, we [2] and others [29] have shown recently that benign mono-extracellular Ca2+-sensing receptor (CaR) [36 ] , with the human CaR gene mapping to chromosome 3q [37] . clonal tumours develop in a high proportion of parathyroid glands, probably favoured by the existence of This hypothesis was derived from the recent observation that familial hypocalciuric hypercalcaemia polyclonal parathyroid hyperplasia for many years [30] . According to Friedman et al. [22] , a similar ( FHH ), an autosomal dominantly inherited disorder, is associated in most families with a point mutation of scenario might occur in MEN-1 patients in whom monoclonal neoplasms might arise on a background the CaR gene [37] . It was conceivable that a mutation of this gene played a role in the pathogenesis of I°of polyclonal proliferation since tumours with allelic loss were larger than those without such loss.
parathyroid adenoma since in one study loss of chromosomal DNA encompassing the parathyroid CaR To our knowledge, only two studies have been devoted to the exploration of the possible molecular gene occurred in about 10% of sporadic parathyroid adenomas [38] . However, in another study of 44 genetic anomalies underlying monoclonal parathyroid tissue growth in uraemic patients with severe II°HPTH human parathyroid tumours (23 adenomas, 4 carcinomas, 5 primary hyperplasia, and 12 secondary hyper- [2, 31] . In the first report [31] , evidence for an allelic loss on chromosome 11q13 was found in two of 12 plasia) no mutations of the CaR gene were detected [39] . These findings indicate that loss of CaR function parathyroid glands from six patients. Interestingly, the two glands with allelic loss had a significantly greater due to acquired genetic molecular anomalies of its gene probably is a rare event, if it occurs at all, in tissue weight than those without loss of heterozygosity. In the second report [2] , allelic 11q13 loss could not sporadic parathyroid tumours.
Approximately 20% of Wilms' tumours manifest be detected in any of the 18 informative hyperplastic parathyroid glands available from 10 uraemic patients. allelic losses in the region encompassing the WT1 gene [40] . In our study, an allelic loss of the WT1 gene was In contrast, monoclonal allelic loss of heterozygosity on the X-chromosome was found in the hyperplastic detected in parathyroid tissues from three patients with I°HPTH and 1 uraemic patient with II°HPTH. The parathyroid tissue of one uraemic patient.
In the present study we provided evidence for allelic latter observation is a novel finding, particularly for the case of II°HPTH. This is also true for our detection loss in chromosome regions 11p13 and 11p15 in 2 of 25 parathyroid glands removed from uraemic dialysis of an allelic loss of the Ha-ras oncogene, located on chromosome 11p15, in a patient with II°HPTH. patients with severe II°HPTH. We found no indication
